Sleep Apnea and Metabolic Health in NYC: Why Your Blood Sugar, Blood Pressure, and Testosterone Depend on How You Breathe at Night

Obstructive sleep apnea is one of the most common untreated drivers of metabolic disease in New York City, and most patients who have it do not know it. They come to our office for something else entirely — stubborn weight, morning blood pressure that will not come down, fatigue that has outlasted three rounds of bloodwork, low testosterone, or an A1c that keeps creeping up despite a reasonable diet. When we ask about sleep, the story is almost always the same: seven hours in bed, no refreshment, waking once or twice to urinate, a partner who mentions snoring.

At Regen Health Physicians, we screen for sleep-disordered breathing in nearly every metabolic and hormonal workup, because treating insulin resistance, hypertension, or low testosterone while a patient stops breathing thirty times an hour is treating the downstream problem and ignoring the upstream one.

What Obstructive Sleep Apnea Actually Is

Obstructive sleep apnea (OSA) is repetitive collapse of the upper airway during sleep. The muscles that hold the pharynx open lose tone, the airway narrows or closes, airflow stops or drops, and oxygen saturation falls. The brain registers the asphyxial stress and triggers a brief arousal — usually too short to remember — that restores muscle tone and reopens the airway. Then the cycle repeats.

Severity is measured by the apnea-hypopnea index (AHI), the number of these events per hour of sleep:

• Mild: 5–15 events/hour
• Moderate: 15–30 events/hour
• Severe: more than 30 events/hour

The AHI alone is an incomplete picture. Two patients with an AHI of 20 can have very different physiology depending on hypoxic burden — how deep and how long the oxygen desaturations are — and how much sleep fragmentation results. Hypoxic burden, not AHI, tracks most closely with cardiovascular and metabolic risk in the research literature, which is why we read the full study rather than the summary number.

Why It Is Missed So Often

The classic textbook patient is an older, heavy-set man with loud snoring and daytime sleepiness. Real clinical practice looks different. Women more often present with insomnia, fatigue, morning headache, anxiety, and unrefreshing sleep rather than overt sleepiness, and are diagnosed later as a result. Lean patients with narrow airways, retrognathia (a set-back jaw), high-arched palates, large tonsils, or nasal obstruction can have significant apnea at a completely normal BMI. And many high-functioning New Yorkers have normalized exhaustion — they assume everyone feels this way at 3 p.m.

The Metabolic Consequences: Mechanism by Mechanism

OSA is not simply correlated with metabolic disease. There are defined physiologic pathways connecting intermittent hypoxia and sleep fragmentation to the exact markers we measure in the office.

1. Sympathetic Overdrive and Blood Pressure

Every apneic event is a stress event. Chemoreceptors sense falling oxygen and rising CO2 and drive a sympathetic surge — heart rate and vascular tone rise, and blood pressure spikes at the end of each event. Over months and years this resets baseline sympathetic tone even during waking hours.

The clinical fingerprint is non-dipping nocturnal blood pressure: normally blood pressure should drop 10–20% during sleep, and in untreated OSA it often does not. This is why OSA is the single most common identifiable cause of resistant hypertension — blood pressure that remains elevated on three or more agents. If a patient's pressure will not budge on multiple medications, a sleep study is a higher-yield test than adding a fourth drug.

2. Insulin Resistance and Glucose Dysregulation

Intermittent hypoxia impairs insulin sensitivity through several converging routes: catecholamine-driven hepatic glucose output, elevated nocturnal cortisol, increased free fatty acid flux from stressed adipose tissue, and oxidative stress that interferes with insulin receptor signaling in muscle. Sleep fragmentation independently reduces glucose disposal even in healthy volunteers.

In practice, this shows up as a rising fasting insulin, a fasting glucose in the 100–115 range, an A1c that inches from 5.4 to 5.9, and a patient who is genuinely doing the dietary work. Because OSA can drive insulin resistance independent of body weight, treating it belongs in the same conversation as metabolic and chronic disease management, not after it.

3. Weight Gain and the Appetite Loop

Short and fragmented sleep raises ghrelin (hunger) and lowers leptin (satiety), shifts food preference toward refined carbohydrate, and reduces spontaneous physical activity the next day. Weight gain then narrows the airway further through parapharyngeal fat deposition, worsening the apnea. This is the loop most patients are stuck in: the apnea makes weight loss harder, and the weight makes the apnea worse. Breaking it usually requires attacking both ends at once rather than waiting for weight loss to fix the breathing.

4. Testosterone and Growth Hormone Suppression

The largest pulse of both testosterone and growth hormone occurs during consolidated deep (slow-wave) sleep. Apnea fragments exactly this architecture. The result is a measurable drop in morning total and free testosterone, blunted GH pulsatility, and the familiar cluster of low energy, poor recovery, reduced libido, and difficulty adding lean mass.

This matters enormously for how we prescribe. Starting testosterone therapy in a man with untreated severe OSA can worsen the apnea in some patients, and it also papers over a fixable root cause. In our hormone optimization evaluations, a man under 50 with low testosterone, poor sleep, and snoring gets screened for apnea before any decision about therapy is made.

5. Inflammation, Endothelial Function, and Cardiovascular Risk

Cycles of deoxygenation and reoxygenation generate reactive oxygen species in a pattern resembling ischemia-reperfusion injury. The downstream effects — elevated hs-CRP and IL-6, reduced nitric oxide bioavailability, endothelial dysfunction, and increased platelet aggregability — raise risk for atrial fibrillation, coronary disease, stroke, and nonalcoholic fatty liver disease. Nocturnal arrhythmia and early-morning cardiac events cluster in this population for exactly these reasons.

Who Should Be Tested

We recommend evaluation for sleep-disordered breathing when a patient has any of the following:

• Habitual snoring, witnessed pauses in breathing, or gasping arousals
• Resistant or non-dipping hypertension
• Type 2 diabetes, prediabetes, or unexplained insulin resistance
• Low testosterone, particularly in men under 55
• Atrial fibrillation, heart failure, or nocturnal arrhythmia
• Nocturia (waking two or more times nightly to urinate)
• Morning headaches, dry mouth, or bruxism
• Unrefreshing sleep, brain fog, or fatigue that persists after a normal thyroid, iron, and B12 workup
• A crowded oropharynx, large neck circumference (>17 inches men, >16 inches women), nasal obstruction, or a set-back jaw

Validated screening questionnaires (STOP-BANG, Epworth) are useful for stratification but they do not rule apnea out. A patient with a low Epworth score and clear metabolic findings should still be tested.

Home Testing vs In-Lab Polysomnography

For most uncomplicated adults with a high pre-test probability, a home sleep apnea test is appropriate, convenient, and far less expensive. It measures airflow, respiratory effort, oxygen saturation, and heart rate over one or more nights at home. Its limitation is that it does not measure sleep stages, so it can underestimate severity when a patient sleeps poorly during the test.

In-lab polysomnography remains the standard when we suspect central sleep apnea, significant cardiopulmonary or neuromuscular disease, periodic limb movements, narcolepsy, or when a home study is negative but suspicion remains high.

Wearables — rings, watches, mattress sensors — are not diagnostic, but they are genuinely useful for pattern recognition. A device showing consistently low overnight SpO2, high respiratory-rate variability, elevated nocturnal heart rate, and collapsed deep sleep is a reasonable prompt to get a real study.

Treatment: What Actually Changes the Metabolic Picture

CPAP

Continuous positive airway pressure remains the most effective treatment for moderate-to-severe OSA. It reliably eliminates events, restores oxygenation, and consolidates sleep architecture. Its impact on metabolic markers depends heavily on adherence: studies showing minimal glycemic benefit tend to report average nightly use around four hours, while patients using CPAP six to seven hours per night — covering the REM-heavy final third of the night, when apnea is usually worst — show meaningful improvements in blood pressure, insulin sensitivity, and daytime function.

The practical work is therefore mask fit, pressure comfort, humidification, nasal patency, and expectation setting. Most CPAP failures are equipment and coaching failures, not patient failures.

Mandibular Advancement Devices

A custom oral appliance advances the lower jaw and tongue base to enlarge the airway. It is less powerful than CPAP per event but often better tolerated, which can make real-world effectiveness comparable in mild-to-moderate disease. It is a strong option for positional or mild OSA, for travel, and for patients who genuinely cannot tolerate positive pressure.

Positional, Nasal, and Behavioral Therapy

A subset of patients has supine-predominant apnea, where events largely disappear off the back; positional trainers help this group substantially. Treating nasal obstruction — allergic rhinitis, septal deviation, turbinate hypertrophy — improves both CPAP tolerance and baseline airway resistance. Alcohol within three hours of bed, sedative-hypnotics, and muscle relaxants all worsen upper-airway tone and should be addressed honestly.

Weight and Body Composition

A 10% reduction in body weight typically produces a clinically meaningful drop in AHI, and larger reductions can be transformative — though rarely curative on their own. Because the apnea-weight loop cuts both ways, we treat the breathing and the metabolic program simultaneously rather than sequentially. Preserving lean mass during weight loss matters here too: sarcopenic weight loss worsens the metabolic picture we are trying to fix.

Surgical and Device Options

Tonsillectomy in patients with obstructing tonsils, nasal surgery, maxillomandibular advancement, and hypoglossal nerve stimulation are appropriate in selected patients who fail or cannot tolerate other therapy. These are referral decisions made with a sleep surgeon, and we coordinate them rather than perform them.

Where Regenerative and Integrative Medicine Fit — Honestly

There is no injection, peptide, or infusion that opens a collapsing airway. Any clinic implying otherwise is overselling. What we can do is address the metabolic and inflammatory damage that accumulated while the apnea went untreated, and support recovery once the breathing is corrected.

That work includes structured insulin-sensitivity programs, correcting the hormonal deficits that persist after sleep is restored, addressing the inflammatory burden documented on labs, and treating the musculoskeletal pain that fragments sleep for its own reasons. Chronic shoulder, hip, or low-back pain that wakes a patient repeatedly compounds every mechanism described above, and regenerative treatment for joint, back, and shoulder pain can be a legitimate part of restoring sleep continuity. Similarly, selected peptide protocols are used in our practice for recovery and tissue repair support — as adjuncts within a plan, never as a substitute for treating the airway.

We are equally direct about sequencing: we generally do not start testosterone therapy in a patient with untreated severe OSA, and we do not consider a metabolic plan complete if the patient is desaturating nightly.

What to Expect Working With Us

A typical evaluation at Regen Health Physicians proceeds in stages:

1. History and airway exam. Sleep history, partner report, nocturia, headache, bruxism, medication and alcohol review, Mallampati and tonsil grading, neck circumference, nasal patency, jaw position.
2. Metabolic and hormonal laboratory panel. Fasting glucose and insulin with HOMA-IR, A1c, a full lipid panel with ApoB, hs-CRP, liver enzymes, ferritin, thyroid panel, morning total and free testosterone with SHBG and LH where indicated, and a morning cortisol.
3. Objective sleep testing. Home sleep apnea test, or in-lab study when the clinical picture warrants it.
4. Treatment plan. Airway therapy selected with the patient, plus the metabolic, hormonal, and pain-related work that belongs alongside it.
5. Reassessment at 10–14 weeks. Repeat labs, adherence and efficacy data from the device, home blood pressure log, symptom and energy review. We expect measurable movement in fasting insulin, blood pressure, and testosterone in patients who use therapy consistently — and if nothing has moved, that is information, not a reason to keep going unchanged.

Dr. Ajit Dhaliwal sees patients in New York City and Salt Lake City, and much of this evaluation and follow-up can be handled through telemedicine, with testing arranged locally.

Frequently Asked Questions

Can I have sleep apnea if I'm not overweight? Yes. Craniofacial structure, nasal obstruction, tonsillar hypertrophy, and age-related loss of airway muscle tone all cause OSA at a normal BMI. Lean patients are among the most commonly missed.

Will CPAP fix my testosterone? Often it improves it, sometimes substantially, particularly in younger men whose deficiency is driven mainly by sleep disruption. It is not universal. We measure before and again at 10–14 weeks rather than promising a result.

How quickly do metabolic markers improve? Blood pressure and daytime energy often respond within weeks. Fasting insulin, A1c, and testosterone need a full quarter of consistent therapy before the retest is meaningful.

I tried CPAP years ago and hated it. Modern machines, masks, humidification, and auto-titrating pressure are substantially better than the equipment of a decade ago, and alternatives like oral appliances and positional therapy are legitimate. Prior failure is worth revisiting, not treating as a permanent verdict.

Does snoring alone mean I have apnea? No — but it means the airway is vibrating and partially obstructed, and in the presence of hypertension, insulin resistance, or low testosterone it warrants a test.

The Takeaway

If you are being treated for blood pressure, blood sugar, weight, or hormones and nobody has asked how you breathe at night, there is a real chance the most treatable driver of your problem has never been evaluated. Sleep apnea is a mechanical problem with systemic metabolic consequences, and it is one of the few upstream findings in adult medicine where correcting it improves several downstream numbers at once.

Book a consultation with Regen Health Physicians to have your sleep, metabolic, and hormonal picture evaluated together rather than in separate silos. You can also read more on our chronic disease and blog pages.

---

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Obstructive sleep apnea is a medical condition requiring objective testing and individualized care. Do not start, stop, or change any therapy — including CPAP, hormone therapy, or medication — without consulting a qualified physician. Individual results vary.